Your browser doesn't support javascript.
Trends in postpartum mental health care before and during COVID-19.
Rokicki, Slawa; Steenland, Maria W; Geiger, Caroline K; Gourevitch, Rebecca A; Chen, Lucy; Martin, Michelle W; Cohen, Jessica L.
  • Rokicki S; Department of Health Behavior, Society, & Policy, Rutgers School of Public Health, Piscataway, New Jersey, USA.
  • Steenland MW; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Geiger CK; Population Studies and Training Center, Brown University, Providence, Rhode Island, USA.
  • Gourevitch RA; Interfaculty Initiative in Health Policy, Harvard University, Cambridge, Massachusetts, USA.
  • Chen L; Evidence for Access, Genentech, Inc., South San Francisco, California, USA.
  • Martin MW; Interfaculty Initiative in Health Policy, Harvard University, Cambridge, Massachusetts, USA.
  • Cohen JL; Department of Health Policy and Management, University of Maryland, College Park, Maryland, USA.
Health Serv Res ; 57(6): 1342-1347, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2019041
ABSTRACT

OBJECTIVE:

To assess the impact of COVID-19 on trends in postpartum mental health diagnoses and utilization of psychotherapy and prescription drug treatment. DATA SOURCES Data were obtained from a large, national health insurance claims database that tracks individuals longitudinally. STUDY

DESIGN:

We used interrupted time series models to examine changes in trends of postpartum mental health diagnoses before and during the COVID-19 pandemic and t-tests to examine differences in treatment. DATA EXTRACTION

METHODS:

We used billing codes to identify individuals who received mental health-related diagnoses and treatment in the first 90 days after a birth hospitalization. We excluded individuals diagnosed with schizophrenia or bipolar disorder and those with an unknown payer at delivery. PRINCIPAL

FINDINGS:

Compared to the pre-pandemic period, the trend in new postpartum mental health diagnoses increased significantly in the post-COVID-19 period (0.06 percentage points [95%CI 0.01, 0.11]). Over 12 months, the percentage of new diagnoses was 5.0% greater relative to what would be expected in absence of COVID-19. The percentage of diagnosed individuals who did not receive treatment increased from 50.4% to 52.7% (p = 0.003).

CONCLUSIONS:

Findings point to an urgent need to improve screening and treatment pathways for perinatal individuals in the wake of COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bipolar Disorder / COVID-19 Type of study: Experimental Studies / Observational study / Reviews Topics: Long Covid Limits: Female / Humans / Pregnancy Language: English Journal: Health Serv Res Year: 2022 Document Type: Article Affiliation country: 1475-6773.14051

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Bipolar Disorder / COVID-19 Type of study: Experimental Studies / Observational study / Reviews Topics: Long Covid Limits: Female / Humans / Pregnancy Language: English Journal: Health Serv Res Year: 2022 Document Type: Article Affiliation country: 1475-6773.14051